Aktive Positionen von Kevin Colbert
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
LifeSprout, Inc.
 LifeSprout, Inc. BiotechnologyHealth Technology LifeSprout, Inc. commercializes synthetic material made of hydrogel and polyester nanofibers. It aims to change the treatment of soft tissue losses with an injectable synthetic material that mimics living tissue. The company was founded by Russell Martin, Hai-Quan Mao, Justin Sacks, and Sashank Reddy in 2018 and is headquartered in Baltimore, MD. | Geschäftsführer | 01.01.2018 | - |
| Gründer | 01.01.2018 | - |
Karriereverlauf von Kevin Colbert
Ehemalige bekannte Positionen von Kevin Colbert
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Glyscend, Inc.
 Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Glyscend, Inc. engages in the development of therapeutics for treating metabolic diseases. It focuses on providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. The company was founded by Kevin Colbert in September 2014 and is headquartered in Baltimore, MD. | Gründer | 01.09.2014 | - |
Statistik
International
| Vereinigte Staaten | 3 |
Operativ
| Founder | 2 |
| Chief Operating Officer | 1 |
Sektoral
| Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
LifeSprout, Inc.
LifeSprout, Inc. BiotechnologyHealth Technology LifeSprout, Inc. commercializes synthetic material made of hydrogel and polyester nanofibers. It aims to change the treatment of soft tissue losses with an injectable synthetic material that mimics living tissue. The company was founded by Russell Martin, Hai-Quan Mao, Justin Sacks, and Sashank Reddy in 2018 and is headquartered in Baltimore, MD. | Health Technology |
Glyscend, Inc.
Glyscend, Inc. Pharmaceuticals: MajorHealth Technology Glyscend, Inc. engages in the development of therapeutics for treating metabolic diseases. It focuses on providing patients with an effective strategy to keep glucose levels under control and eliminate potential side effects like weight gain and hypoglycemia. The company was founded by Kevin Colbert in September 2014 and is headquartered in Baltimore, MD. | Health Technology |
- Börse
- Insiders
- Kevin Colbert
- Erfahrung
